These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 34068380)

  • 1. Antidiabetic and Other Therapies Used in Subjects with Diabetes and Chronic Kidney Disease in a Hospital-Based Clinic Population in Greece.
    Migdalis IN; Papanas N; Ioannidis IM; Sotiropoulos AE; Raptis AE; Dimitriadis GD; On Behalf Of The Hellenic Diabetic Nephropathy Study Hdns
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34068380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of diabetic chronic kidney disease in adult Greek subjects with type 2 diabetes mellitus: A series from hospital-based diabetes clinics.
    Migdalis IN; Papanas N; Raptis AE; Ioannidis IM; Sotiropoulos AE; Dimitriadis GD;
    Diabetes Res Clin Pract; 2020 Aug; 166():108243. PubMed ID: 32502694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia and Other Risk Factors of Chronic Kidney Disease in Type 2 Diabetes: A Hospital-Based Clinic Population in Greece.
    Migdalis IN; Ioannidis IM; Papanas N; Raptis AE; Sotiropoulos AE; Dimitriadis GD; On Behalf Of The Hellenic Diabetic Nephropathy Study Hdns
    J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
    Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
    Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, epidemiological study of the treatment patterns, comorbidities and hypoglycemia events of patients with type 2 diabetes and moderate or severe chronic kidney disease - the 'LEARN' study.
    Rombopoulos G; Panitti E; Varounis C; Katsinas C; Stefanidis I; Goumenos D
    Curr Med Res Opin; 2016 May; 32(5):939-47. PubMed ID: 26857244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
    Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends in optimal diabetic care and complications of elderly type 2 diabetes patients in Thailand: A nationwide study.
    Kaewput W; Thongprayoon C; Mungthin M; Jindarat S; Varothai N; Suwannahitatorn P; Rangsin R; Mao MA; Cheungpasitporn W
    J Evid Based Med; 2019 Feb; 12(1):22-28. PubMed ID: 30398014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative.
    De Cosmo S; Viazzi F; Pacilli A; Giorda C; Ceriello A; Gentile S; Russo G; Rossi MC; Nicolucci A; Guida P; Di Bartolo P; Pontremoli R;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1526-33. PubMed ID: 25883195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns of antidiabetic and kidney protective therapies among patients with type 2 diabetes mellitus and chronic kidney disease in Colombia. The KDICO descriptive study.
    Machado-Duque ME; Gaviria-Mendoza A; Valladales-Restrepo LF; Franco JS; de Rosario Forero M; Vizcaya D; Machado-Alba JE
    Diabetol Metab Syndr; 2023 Jul; 15(1):150. PubMed ID: 37403118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.
    Selim S; Alam MS; Talukder SK; Kabir ML; Gaffar AJ; Kabir MA; Zarin N; Rahman S; Nabi MMU; Mustari M; Hossain MF; Raunak AIB; Hoque MA; Islam MR; Akter F; Hannan MA; Saifuddin M; Asaduzzaman M; Rahman MM; Ahammed A; Rafi MA; Hasan MJ; Kamrul-Hasan ABM
    BMC Endocr Disord; 2023 Dec; 23(1):268. PubMed ID: 38053073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
    Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
    Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DPP-4 Inhibitors in Diabetic Patients with Chronic Kidney Disease and End-Stage Kidney Disease on Dialysis in Clinical Practice.
    Abe M; Okada K
    Contrib Nephrol; 2015; 185():98-115. PubMed ID: 26023019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl Peptidase-4 inhibitors use in type II diabetic patients in a tertiary hospital.
    Mak WY; Nagarajah JR; Abdul Halim H; Ramadas A; Mohd Pauzi Z; Pee LT; Jagan N
    J Pharm Policy Pract; 2020; 13():34. PubMed ID: 32566235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.
    Busch M; Nadal J; Schmid M; Paul K; Titze S; Hübner S; Köttgen A; Schultheiss UT; Baid-Agrawal S; Lorenzen J; Schlieper G; Sommerer C; Krane V; Hilge R; Kielstein JT; Kronenberg F; Wanner C; Eckardt KU; Wolf G;
    BMC Nephrol; 2016 Jun; 17(1):59. PubMed ID: 27286816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment choices for the glycaemic management of patients with type 2 diabetes and chronic kidney disease: Analysis of the SAIL patient linked dataset.
    Min T; Davies GI; Rice S; Chess J; Stephens JW
    Diabetes Metab Syndr; 2018; 12(2):123-127. PubMed ID: 29239764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE).
    Tan X; Divino V; Amamoo J; Xie L; Coyle KB; Gamble CL; Guevarra M; Paprocki Y; King AA
    Clin Drug Investig; 2024 Apr; 44(4):271-284. PubMed ID: 38507188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).
    Bayram F; Sonmez A; Haymana C; Sabuncu T; Dizdar OS; Gurkan E; Carlioglu AK; Agbaht K; Ozdemir D; Demirci I; Barcin C; Salman S; Tetiker T; Balci MK; Kebapci N; Ersoy C; Yumuk V; Toth PP; Satman I;
    Lipids Health Dis; 2020 Nov; 19(1):237. PubMed ID: 33176832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of anemia in patients with type II diabetes and mild to moderate chronic kidney disease and the impact of anti-RAS medications.
    Dousdampanis P; Trigka K; Fourtounas C
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):552-7. PubMed ID: 24821151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies.
    Liatis S; Iraklianou S; Kazakos K; Mastorakos G; Milios K; Mouslech Z; Noutsou M; Pagkalos E; Sampanis C;
    BMC Endocr Disord; 2019 Apr; 19(1):39. PubMed ID: 31023374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective, Observational Study to Determine the Choice of Antihypertensive agent According to Stage of Hypertension, Risk factors and Co-morbidities in Real World Setting in India: A Report of Baseline Data.
    Khan MY; Pandit S; Dalal J; Bansal S; Iyengar SS; Karnik R; Khanna U; Mane A; Mehta S; Shah S
    J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.